Fierce Pharma

OCTOBER 15, 2024

Nearly six months after lodging a similar complaint against Pfizer and BioNTech over the partners’ COVID shot Comirnaty, GSK is targeting Moderna in a pair of lawsuits alleging the Massachusetts-ba | GSK is targeting Moderna in a pair of lawsuits claiming the mRNA specialist violated multiple patents with its vaccines Spikevax and mRESVIA. In the complaints, GSK says it hopes to recover a “reasonable royalty” tied to Moderna’s vaccine sales, plus damages.

Sales 305

Sales 305

MedCity News

OCTOBER 15, 2024

Payers and providers alike are struggling with data interoperability. It’s clear that a more unified approach to data management is essential for payers to effectively navigate the complexities of value-based care. The post Finding the Cure for Data Interoperability in Value-Based Care appeared first on MedCity News.

Management 112

Management 112

Fierce Pharma

OCTOBER 15, 2024

Jazz Pharmaceuticals’ Zepzelca, once on the brink of a market withdrawal, has returned with new trial results showing it could prolong patients’ lives in extensive-stage small cell lung cancer (ES- | Jazz Pharmaceuticals’ Zepzelca, once on the brink of a market withdrawal, has returned with new trial results showing it could prolong patients’ lives in extensive-stage small cell lung cancer.

Pharmaceutical 243

Pharmaceutical Marketing Patients 243

MedCity News

OCTOBER 15, 2024

Healthcare is a data-driven industry, but it’s held together by incompatible, siloed data systems. Providers and payers need the ability to exchange data and update directories in real time; otherwise, they cannot ensure patients will access the high-quality care they deserve. The post Inaccurate Provider Data Hinders Value-based Care, But it Doesn’t Have To appeared first on MedCity News.

Healthcare 109

Healthcare Healthcare Patients Physicians 109

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Fierce Pharma

OCTOBER 15, 2024

Johnson & Johnson's immunology superstar Stelara and oncology blockbuster Darzalex have long been among the company's top revenue contributors. | The company picked up a record $3 billion in quarterly sales for its multiple myeloma powerhouse Darzalex as it grooms Tremfya to take on Stelara's market dominance.

Sales 154

Sales Marketing 154

PharmaVoice

OCTOBER 15, 2024

A Nobel Prize in chemistry for Google’s DeepMind protein-structure mapping is the tip of the iceberg for advances in drug discovery and development.

111

111

MedCity News

OCTOBER 15, 2024

Headspace recently introduced Ebb, an empathetic AI companion. It helps users reflect and sort through their emotions, and provides recommendations for mental health content. The post Headspace Introduces AI Companion To Support Patients Through ‘Ebbs and Flows’ of Life appeared first on MedCity News.

Patients 101

Patients 101

pharmaphorum

OCTOBER 15, 2024

GSK has filed lawsuits against Moderna, claiming infringement of patents covering mRNA vaccines for COVID-19 and RSV

111

111

Pharmaceutical Technology

OCTOBER 15, 2024

Huawei hosted GITEX's Industrial Digital and Intelligent Transformation Summit and launched joint solutions with partners for ten industries.

93

93

MedCity News

OCTOBER 15, 2024

PurpleLab® stands out from others in this sector by providing its data analytics services to several different groups of users across healthcare and pharma companies. The post The Future of Hospitals and Pharma Companies Will Depend on Strength of Healthcare Analytics Insights appeared first on MedCity News.

Healthcare 89

Healthcare Healthcare Pharma Pharmaceutical 89

Advertisement

pharmaphorum

OCTOBER 15, 2024

Health plans, employers, and healthcare providers plan to increase their spending on digital health technologies in the next 12 months, says PHTI survey

Healthcare Provider 88

Healthcare Provider Healthcare Healthcare 88

MedCity News

OCTOBER 15, 2024

In addition to meeting the main safety and tolerability goal, MieraGTx Holdings’ gene therapy for Parkinson’s disease also showed signs of efficacy. The one-time treatment is intended to reprogram dysfunctional brain circuits. The post On Heels of Positive Parkinson’s Gene Therapy Data, MeiraGTx Looks Ahead to Pivotal Test appeared first on MedCity News.

Safety 69

Safety Biopharma Pharma 69

pharmaphorum

OCTOBER 15, 2024

Transgene's therapeutic vaccine for cervical and anogenital cancers failed a phase 2 trial, but an efficacy signal warrants further study

79

79

MedCity News

OCTOBER 15, 2024

Generative AI-powered voice platform Parakeet Health announced its launch and $3 million in seed funding. The startup seeks to automate many of the interactions that patients have with their doctor’s staff, such as scheduling appointments and answering billing questions. The post Parakeet Health Flies Onto The Scene to Automate Healthcare Call Centers appeared first on MedCity News.

Healthcare 66

Healthcare Healthcare Doctors Patients 66

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales

PharmaTimes

OCTOBER 15, 2024

Study reveals potential new strategy for managing inflammatory bowel disease

Management 99

Management 99

pharmaphorum

OCTOBER 15, 2024

Germany is the first market for LEO Pharma's Anzupgo, the first topical treatment specifically approved for chronic hand eczema

Marketing 77

Marketing Pharma 77

Pharmaceutical Technology

OCTOBER 15, 2024

Lundbeck is to acquire Longboard for $2.6bn equity value in a move set to enhance its capabilities within neuro-rare conditions.

Pharmaceutical 72

Pharmaceutical 72

PharmaTech

OCTOBER 15, 2024

The global CRDMO said its clients would be able to expedite R&D processes, thereby reducing costs and potentially leading to accelerated discovery of new candidate therapies.

Leads 52

Leads 52

Advertisement

Distribution

PharmExec

OCTOBER 15, 2024

Highlighting two pieces beyond Pharm Exec's October headliners that draw interesting parallels when it comes to life sciences leadership and building teams and capability internally—whether new businesses or new brands.

Biopharma 52

Biopharma 52

PharmaTech

OCTOBER 15, 2024

Amid surging drug shortages and costly launch delays, it’s crucial to enhance operational flexibility and efficiency without compromising quality. Discover how end-to- end integrated automation systems can streamline your processes, improve flexibility, reduce time-to-market, maximize revenue, and drive continuous improvement. Transform your pharmaceutical manufacturing processes today!

Pharmaceutical manufacturing 52

Pharmaceutical manufacturing Manufacturing Pharmaceutical Marketing 52

Pharmaceutical Commerce

OCTOBER 15, 2024

William Sarraille, professor, University of Maryland Francis King Carey School of Law, discusses breakout session and the impact of healthcare policies on manufacturing and commercialization.

Healthcare 52

Healthcare Healthcare Manufacturing 52

PharmaTech

OCTOBER 15, 2024

Revolutionize pharmaceutical manufacturing through paperless manufacturing. By eliminating paper-based processes, you can quickly centralize your data, reduce cost and time, minimize errors, and release products faster. Even the simplest “paper on glass” digital systems enable streamlined workflows and can ensure real-time data access and seamless communication.

Manufacturing 52

Manufacturing Pharmaceutical Pharmaceutical manufacturing 52

Advertisement

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

Safety

PharmExec

OCTOBER 15, 2024

Industry leaders gather to discuss different ways life sciences organizations can champion their environmentally-conscious younger employees while combatting still-entrenched public mistrust.

Pharma 52

Pharma 52

PharmaTech

OCTOBER 15, 2024

The design of the center prioritizes integration of the entire supply chain, with the end goals of accelerating product development and autonomous production capacity in alignment with EU priorities.

52

52

PharmExec

OCTOBER 15, 2024

As the overall industry pipeline of allogeneic T-cell therapies expands, the onus on manufacturers and their partners to adeptly manage the complex cryogenic logistics process intensifies.

Manufacturing 52

Manufacturing Management 52

European Pharmaceutical Review

OCTOBER 15, 2024

A report by MarketResearch.biz predicts that the global automated microbiology market will reach $16.2 billion by 2033. This sector will secure a CAGR of 9.3 percent between 2024 and 2033, the research, the research forecast. The global automated microbiology market is projected to experience “substantial growth” in 2024, driven by technological advancements and the increasing demand for efficient and accurate microbial testing.

Marketing 52

Marketing Education Training Management 52

Advertisement

Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud

Distribution

PharmExec

OCTOBER 15, 2024

In this part of her video interview, Amanda Powers-Han, Chief Marketing Officer, Greater Than One and Pharmaceutical Executive Advisory Board Member discusses how pharmaceutical companies can effectively balance personalized marketing efforts with maintaining data privacy and ensuring patient trust.

Marketing 52

Marketing Pharmaceutical Patients 52

Zymewire

OCTOBER 15, 2024

In our Q3 2024 biopharma recap, we dive into the latest trends in funding, clinical trial activity, and therapeutic focus areas across the industry. With updated data on regional funding shifts and insights into the evolving biopharma landscape, this report will help CROs and CDMOs refine their strategies as they prepare for 2025. You can visit this page to download all charts from this report.

Biopharma 52

Biopharma FDA 52

eMediWrite

OCTOBER 15, 2024

Creating marketing materials that truly connect with healthcare professionals (HCPs) and decision-makers in the congested pharmaceutical market can be difficult. Generic and boring content is often the cause of low brand recall. Here are 5 ways to address these issues and create materials with a strong effect that endure: Prioritize Clarity and Simplicity Data-heavy information and complicated medical content might be overwhelming for HCPs.

Marketing 52

Marketing Pharma Pharmaceutical Healthcare 52

Pharmaceutical Technology

OCTOBER 15, 2024

Pharmaceutical giants cannot work in a silo to reach net zero. Pharma contract manufactures have a duty to engage with the science-based climate targets, says ACG.

Manufacturing 52

Manufacturing Pharma Pharmaceutical 52

Advertisement

Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.

Safety